News

Head/Neck Cancer Treatments Less Effective in HIV Patients

Publish date: January 26, 2012

 

FROM A HEAD AND NECK CANCER SYMPOSIUM BY THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY

Dr. Mourad and his nine coauthors declared that they had no financial disclosures.

Pages

Recommended Reading

Biomarkers May Improve Lung Cancer Screening
MDedge Internal Medicine
Glucarpidase Approved to Treat Methotrexate Toxicity
MDedge Internal Medicine
Regorafenib Anticipated to Show Survival Advantage in Colorectal Cancer
MDedge Internal Medicine
Less May Be More in Treating High-Risk Myeloma
MDedge Internal Medicine
U.S. Oncologists Confront Pressure to Curb Cancer Costs.
MDedge Internal Medicine
BRCA1/2 Mutations Tied to Better Ovarian Cancer Survival
MDedge Internal Medicine
Gastric Cancer Subtype May Affect Bevacizumab Benefit
MDedge Internal Medicine
Bevacizumab Boosts Treatment Responses in Early Breast Cancer
MDedge Internal Medicine
Oral HPV Infection More Prevalent in Men Than Women
MDedge Internal Medicine
Cancer Screening Falls Short of Federal Targets
MDedge Internal Medicine